Medtronic CEO On The Company's New Valve Product And How Covidien's Integration Is Progressing

By: via Benzinga
Medtronic PLC (NYSE: MDT) on Tuesday got FDA's approval for its CoreValve Evolut R System. CEO Omar Ishrakwas on CNBC ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.